Phorbol dibutyrate and ionomycin improve murine effector cell cytotoxicity

Area of Science:

• Immunology
• Cell Biology
• Cancer Therapy

Background:

• Protein kinase C (PKC) and calcium signaling pathways regulate lymphocyte activation and proliferation.
• Interleukin-2 (IL-2) is crucial for the expansion and function of cytotoxic lymphocytes.

Purpose of the Study:

• To investigate the impact of simultaneous PKC stimulation (phorbol 12,13-dibutyrate, PDBU) and calcium mobilization (ionomycin, Io) on murine splenocytes and tumor-infiltrating lymphocytes (TIL).
• To evaluate the efficacy of PDBU + Io-stimulated lymphocytes in adoptive immunotherapy models.

Main Methods:

• Murine splenocytes and TIL were exposed to PDBU + Io for 16 hours.
• Lymphokine-activated killer (LAK) and TIL cultures were assessed for cytotoxic effector cell expansion and DNA synthesis.
• In vitro and in vivo tumor models were used to evaluate the therapeutic efficacy of stimulated lymphocytes.

Main Results:

• PDBU + Io significantly increased cytotoxic effector cell generation in LAK (40-fold) and TIL (10-fold) cultures.
• TIL exposed to PDBU + Io showed enhanced DNA synthesis and significantly greater tumor-specific lytic activity in vitro.
• Adoptive immunotherapy with PDBU + Io-stimulated TIL resulted in a significant reduction of pulmonary nodules and maintained in vivo activity without systemic IL-2.

Conclusions:

• Pharmacologic manipulation of cytotoxic precursor cells using PDBU + Io is an effective strategy for enhancing cytotoxic lymphocyte generation and activity.
• PDBU + Io stimulation offers a promising approach for improving adoptive immunotherapy, particularly for TIL-based treatments.
• This method enables the generation of cytotoxic lymphocytes with improved in vitro and in vivo therapeutic potential.